Aurobindo Receives FDA Approval for Tenofovir Disoproxil Fumarate Tablets
East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Tenofovir Disoproxil Fumarate Tablets, 150 mg, 200 mg, 250 mg, and 300 mg. Aurobindo’s Tenofovir Disoproxil Fumarate Tablets are an AB-rated generic equivalent to the reference listed drug VIREAD®. Tenofovir […]
Aurobindo Receives FDA Approval for Tenofovir Disoproxil Fumarate Tablets Read More »